J. Trojnar

发表

Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.

R. Houghten, F. Menzaghi, P. Rivière, 2008, European journal of pharmacology.

Early appearance of simian immunodeficiency virus (SIV) antigen and antibodies as variables in evaluating antiviral drugs in macaques.

B. Oberg, B. Wahrén, E. Ljungdahl-Ståhle, 1992, Journal of virological methods.

Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.

P. Rivière, J. Junien, J. Trojnar, 2003, The Biochemical journal.

Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor

I. Olafsson, L. Björck, M. Bohus, 1989, Nature.

Ig-binding bacterial proteins also bind proteinase inhibitors.

L. Björck, A. Grubb, U. Sjöbring, 1989, Journal of immunology.

Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length.

M. Abrahamson, F. Kasprzykowski, A. Grubb, 1992, Journal of enzyme inhibition.

Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms.

G. Guillon, C. Serradeil-Le Gal, M. Trueba, 2004, European journal of pharmacology.

The synthesis of a new class of oxytocin antagonists.

P. Rivière, P. Melin, A. Nilsson, 1999, Bioorganic & medicinal chemistry letters.

The Effects of a I Hormone-Releas Rats

I. Robinson, R. Clark, J. Trojnar, 2006 .

The Effects of a Growth Hormone‐Releasing Peptide and Growth Hormone‐Releasing Factor in Conscious and Anaesthetized Rats

I. Robinson, R. Clark, J. Trojnar, 1989, Journal of neuroendocrinology.

Synthetic antagonists of the myometrial response to vasopressin and oxytocin.

M. Åkerlund, P. Melin, H. Vilhardt, 1986, The Journal of endocrinology.

THE EFFECT ON THE HUMAN UTERUS OF TWO NEWLY DEVELOPED COMPETITIVE INHIBITORS OF OXYTOCIN AND VASOPRESSIN

M. Åkerlund, P. Melin, A. Carlsson, 1985, Acta obstetricia et gynecologica Scandinavica.

Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women

S. Lundin, M. Åkerlund, P. Melin, 1986, British journal of obstetrics and gynaecology.

Epitope mapping of anti‐glomerular basement membrane (GBM) antibodies with synthetic peptides

J. Wieslander, T. Hellmark, C. Brunmark, 1996, Clinical and experimental immunology.

A cyclized peptide for studies of human parvovirus B19 infection.

B. Wahrén, H. Mehlin, J. Trojnar, 1991, Journal of immunological methods.

Synthesis of cysteine proteinase inhibitors structurally based on the proteinase interacting N-terminal region of human cystatin C.

I. Olafsson, M. Abrahamson, F. Kasprzykowski, 1990, Biological chemistry Hoppe-Seyler.

Practical Synthesis of (+)-Alloisoleucine

M. Chmielewski, J. Trojnar, C. Belzecki, 2000 .

An Automated System for the Statistical Evaluation of Developmental Toxicology Data

Robert L. Clark, Joseph F. Heyse, Joseph M. Antonello, 1991 .

GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6.

J. Rivier, M. Aubert, P. Rivière, 2001, Journal of medicinal chemistry.

FE200041 (d-Phe-d-Phe-d-Nle-d-Arg-NH2): A Peripheral Efficacious κ Opioid Agonist with Unprecedented Selectivity

P. Rivière, T. Vanderah, J. Junien, 2004, Journal of Pharmacology and Experimental Therapeutics.

Immunosuppressive activity of antamanide and some of its analogues

I. Siemion, Z. Wieczorek, J. Trojnar, 1992, Peptides.

Effects of vasopressin on the human non-pregnant uterus: studies with analogues of different vasopressor potencies.

M. Åkerlund, P. Melin, A. Carlsson, 1988, European journal of pharmacology.

Development of vasopressor specific vasotocin analogues with prolonged effects

R. Persson, P. Melin, A. Nilsson, 1991 .

Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study

M. Åkerlund, P. Melin, L. F. Andersen, 1988, British journal of obstetrics and gynaecology.

Synthesis and pharmacological properties of some Carba-6 and Carba-1 oxytocin antagonists

R. Persson, P. Melin, A. Nilsson, 1993 .

Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study

M. Åkerlund, P. Melin, L. F. Andersen, 1987 .

A new peptide for human parvovirus B19 antibody detection.

B. Wahrén, J. Trojnar, E. Fridell, 1989, Scandinavian journal of infectious diseases.

Molecular basis for antibody cross‐reactivity between the hepatitis C virus core protein and the host‐derived GOR protein

M. Chen, M. Sällberg, Z. Zhang, 1994, Clinical and experimental immunology.

Analogs of Deamino Carba Oxytocin with Inhibitory Properties; Synthesis and Biological Activities

M. Lebl, T. Barth, J. Slaninová, 1992 .

Immunosuppressive activity of cyclolinopeptide A.

I. Siemion, Z. Wieczorek, I Z Siemion, 1991, Peptide research.

Fine analysis of intrathecally synthesized anti-HIV IgG1-4 by peptide mapping

A. Sönnerborg, B. Wahrén, J. Trojnar, 1990, Journal of the Neurological Sciences.

Novel peripheral peptidic kappa agonists

R. Houghten, T. Vanderah, F. Porreca, 1999 .

Blockade of sensory nerve mediated contraction of the rabbit iris sphincter by a series of novel tachykinin antagonists

R. Håkanson, K. Folkers, S. Leander, 1988, Regulatory Peptides.

Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection.

G. de Thé, B. Wahrén, J. Trojnar, 1991, Journal of acquired immune deficiency syndromes.

Study of New Oxytocin Antagonist Barusiban (Fe200 440) Affinity Toward Human Oxytocin Receptor Versus Vasopressin V1a and V2 Receptors – Molecular Dynamics Simulation in POPC Bilayer

R. Meadows, R. Ślusarz, A. Giełdoń, 2005 .

Novel, water soluble and long acting GnRH antagonists

J. Rivier, M. Aubert, P. Rivière, 2002 .